Source: Annual Congress 2001 - Worldwide prevalence of asthma and atopy in children
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. L. Maksimovic, D. Begovic, M. Voros, M. Popovic, T. Stojanovic (Belgrade, Yugoslavia). Prevention of paediatric asthma and allergy by reduction of house dust mite content. Eur Respir J 2001; 16: Suppl. 31, 1920

Member's Comments

No comment yet.

Related content which might interest you: Efficacy of specific allergy vaccination in house dust mite asthma Source: Eur Respir J 2005; 26: Suppl. 49, 465s Year: 2005 OPURIT: Omalizumab-protected ultra rush specific immunotherapy in severe asthmatic patients with house dust mite allergy Source: Annual Congress 2011 - Allergen immunotherapy and anti-immunoglobulin E Year: 2011 The reduction of the house dust mite as a prevention component in a treatment of the asthmatic children Source: Eur Respir J 2002; 20: Suppl. 38, 335s Year: 2002 Association between dust mite sensitisation and asthma severity Source: Annual Congress 2010 - Clinical aspects of asthma and allergic respiratory diseases Year: 2010 House dust mite (HDM) avoidance and treatment of severe childhood asthma Source: Eur Respir J 2003; 22: Suppl. 45, 314s Year: 2003 The effect of anti-mite mattress covers on mite allergen levels in the PIAMA (prevention and incidence of asthma and mite allergy) study Source: Eur Respir J 2001; 18: Suppl. 33, 321s Year: 2001 Late Breaking Abstract - Budget impact of introducing 12SQ HDM SLIT-tablet for house dust mite allergic asthma in Spain Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness Year: 2019 Bacteria and mould components in house dust and children's allergic sensitisation Source: Eur Respir J 2007; 29: 1144-1153 Year: 2007 House dust mite allergen exposure is associated with sensitisation and asthma in New Zealand infants Source: Eur Respir J 2002; 20: Suppl. 38, 117s Year: 2002 Hypoallergenic high dose scit as add-on therapy in children with allergic asthma caused by house dust mites Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009 Impact of asthma-associated genetic polymorphisms on the efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma Source: Virtual Congress 2021 – Asthma treatment: clinical and translational science Year: 2021 Safety of subcutaneous immunotherapy with standardized extracts of house dust mite in allergic asthmatic subjects Source: Eur Respir J 2002; 20: Suppl. 38, 57s Year: 2002 High-altitude treatment in atopic and nonatopic patients with severe asthma Source: Eur Respir J 2012; 40: 1374-1380 Year: 2012 Calcaratarin D attenuates house dust mite-induced allergic asthma Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 High altitude and asthma: beyond house dust mites Source: Eur Respir J 2012; 40: 1320-1321 Year: 2012 Exposure to gas, dust and fumes increases the risk of mite sensitisation and asthma Source: International Congress 2014 – Risk factors for respiratory disease Year: 2014 Concentration of house dust mites, respiratory symptoms and atopy markers Source: Eur Respir J 2005; 26: Suppl. 49, 680s Year: 2005 Association between house dust mites (HDM) level in homes of atopic children and interleukine-4 and IgE in expired air condensate(EAC) Source: Eur Respir J 2002; 20: Suppl. 38, 536s Year: 2002 Sublingual tablets of house dust mite allergen extracts: Results of a phase I study in adults with mite-associated allergic asthma Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Association between Th2 biomarker levels and efficacy of house dust mite sublingual allergy immunotherapy in adults with allergic asthma Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies Year: 2021